Agilent Technologies
AA · Stock Price
Historical price data
Overview
Agilent Technologies is a mission-driven company dedicated to delivering trusted answers and insights that advance the quality of life. Since its strategic pivot to focus exclusively on life sciences, diagnostics, and applied markets in 2014, it has achieved consistent growth through a balanced portfolio of high-end instrumentation and high-margin recurring services. Its strategy centers on innovation in analytical workflows, expansion of its services ecosystem, and capitalizing on secular trends in biopharma productivity, precision medicine, and quality assurance across key industries.
Technology Platform
A broad, integrated platform of analytical instrumentation (LC/GC-MS, spectroscopy, automation), informatics software, and genomics tools that enable end-to-end workflows for life science research, applied chemical analysis, and clinical diagnostics.
Pipeline
1| Drug | Indication | Stage | Watch |
|---|---|---|---|
| NK Cell enriched-DLI only + NK-DLI + DUK-CPG-001 | Myeloid Malignancies | Phase 2 |
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Agilent competes with giants like Thermo Fisher Scientific and focused leaders like Waters and Bruker in instrumentation, and with Roche and Illumina in genomics/diagnostics. Its differentiation lies in integrated workflow solutions, unparalleled instrument reliability, and a deeply embedded, high-margin services business that creates customer loyalty and financial stability.